Companies: 10,795·Total market cap: $144.5T

Lucid Diagnostics Inc.

Lucid Diagnostics Inc.

LUCDNASDAQHealthcare● Active

$0.96

$-0.01(-0.94%)

Market Cap$98017795

P/E Ratio—

52W High$1.629

52W Low$0.9

Avg Volume805K

Open$0.98

Beta1.08

Net Income Financials Revenue

Lucid Diagnostics Inc. (LUCD) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

LUCD · net income · updated Jun 9, 2026

Core profitability metrics

LUCD · net income · margin · TTM · CAGR

Net income was −$58.0M for FY2025 (fiscal year ending 2025-12-31), down 27.4% year-over-year. Net profit margin was -1232.7%.

FY2025 Net Income−$58.0M▼ -27.4% YoY

Trailing 12M (TTM)−$45.0Mtrailing 4 quarters sum

Net Profit Margin< −999%−$58.0M ÷ $4.7M

YoY Change-27.4%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · LUCD net income history · LUCD profit margin

Annual net income data

LUCD · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$58.0M▼ 27.4%-1232.7%$4.7M

FY2024Loss−$45.5M▲ +13.6%-1047.6%$4.3M

FY2023Loss−$52.7M▲ +6.2%-2169.1%$2.4M

FY2022Loss−$56.2M▼ 100.1%-14899.5%$377,000

FY2021Loss−$28.1M▼ 239.1%-5615.6%$500,000

Net income vs peers (Healthcare)

LUCD vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Lucid Diagnostics Inc.YOU

LUCD

−$58.0M-27.4%-1232.7%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Lucid Diagnostics Inc. (LUCD) reported net income of −$58.0M for FY2025 (fiscal year ending 2025-12-31), down 27.4% year-over-year. The net profit margin was -1232.7% — meaning the company kept $-12.33 of every dollar of revenue as profit.

Lucid Diagnostics Inc. has not yet achieved annual profitability based on available data (8 fiscal years). The company has reported net losses across all available periods.

Lucid Diagnostics Inc.'s net profit margin was -1232.7% for FY2025, based on the latest annual results.

Investors sometimes search for "Lucid Diagnostics Inc. net worth" — the company's market capitalization is a separate figure from LUCD net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

LUCD net income · 4 questions

Lucid Diagnostics Inc. is not currently profitable on an annual basis. The company reported a net loss of $58.0M for FY2025.

is LUCD profitabledoes LUCD make a profitLUCD profitabilityLUCD profitable company

▸ Source: FMP /income-statement · GAAP · Lucid Diagnostics Inc. · Lucid Diagnostics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026